Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms
John Thompson, Alice Thornton, Timothy J. Ainger, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 22

Showing 22 citing articles:

Long COVID, the Brain, Nerves, and Cognitive Function
Allison B. Reiss, C. E. Greene, Christopher Dayaramani, et al.
Neurology International (2023) Vol. 15, Iss. 3, pp. 821-841
Open Access | Times Cited: 42
Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies
Danilo Buonsenso, Laura Martino, Rosa Morello, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e745-e756
Open Access | Times Cited: 30
Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in Long COVID Patients Compared to No-Long-COVID Populations: A Case-Control Study
Emilie Han, Katrin Zlabinger, Ena Hašimbegović, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 300-300
Open Access
Cardiorespiratory dysautonomia in post‐COVID‐19 condition: Manifestations, mechanisms and management
Artur Fedorowski, Monika Fagevik Olsén, Frida Nikesjö, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 5, pp. 548-562
Open Access | Times Cited: 15
Positionspapier zum Post-COVID-Syndrom
Elisabeth Schieffer, Denise Hilfiker‐Kleiner, Axel Schlitt, et al.
Deleted Journal (2025)
Closed Access
Characterizing long-COVID brain fog: a retrospective cohort study
Grace Y. Lam, Ronald W. Damant, Giovanni Ferrara, et al.
Journal of Neurology (2023) Vol. 270, Iss. 10, pp. 4640-4646
Closed Access | Times Cited: 12
Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
Brittany Adler, Tae Hwan Chung, Peter C. Rowe, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 4
Fascia as a regulatory system in health and disease
Alison M. Slater, S. Jade Barclay, Rouha M. S. Granfar, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
A practical framework for Long COVID treatment in primary care
W. Michael Brode, Esther Melamed
Life Sciences (2024) Vol. 354, pp. 122977-122977
Open Access | Times Cited: 2
Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach
Daniel O. Griffin
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 9
Open Access | Times Cited: 2
Cardiovascular dysautonomia in postacute sequelae of SARS‐CoV‐2 infection
Marcus Ståhlberg, Ali Mahdi, Madeleine Johansson, et al.
Journal of Cardiovascular Electrophysiology (2023) Vol. 35, Iss. 3, pp. 608-617
Closed Access | Times Cited: 5
Intravenous immunoglobulin as a potential treatment for long COVID
Matthew W. McCarthy
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 12, pp. 1211-1217
Closed Access | Times Cited: 4
Disautonomias Pós-COVID: Importância do Reconhecimento Precoce e da Implementação de Programas de Recuperação
Denise Hachul, Tatiana Frederico de Almeida, Maurício Scanavacca
Arquivos Brasileiros de Cardiologia (2023) Vol. 120, Iss. 3
Open Access | Times Cited: 3
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Junzheng Wu, Huichuan Yang, Ding Yu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 2
A Practical Framework for Long COVID Treatment in Primary Care
W. Michael Brode, Esther Melamed
(2024)
Open Access
Expression of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) in Normal Wistar Rat Post-Cheral® Administration
Firda Nuri Asyhari, Heni Sukma Zulfatim, Nenis Try Melani Putri, et al.
HAYATI Journal of Biosciences (2024) Vol. 31, Iss. 5, pp. 1030-1036
Open Access
A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and post-acute sequelae of COVID-19 Syndrome
Brinkley Morse, Katherine Motovilov, W. Michael Brode, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 725-738
Open Access
Neutralizing activity of anti–SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants
Lorenza Bellusci, Hana Golding, Surender Khurana
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access
Beyond Antivirals: Alternative Therapies for Long COVID
Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses (2024) Vol. 16, Iss. 11, pp. 1795-1795
Open Access
Intravenous immunglobulin as a therapy for autoimmune conditions
Maria Giovanna Danieli, Eleonora Antonelli, Luca Gammeri, et al.
Autoimmunity Reviews (2024), pp. 103710-103710
Open Access
Treatment of Cognitive Deficits and Behavioral Symptoms Following COVID-19-Associated Autoimmune Encephalitis With Intravenous Immunoglobulin: A Case Report and Review of the Literature
Suniya Naeem, Sarah M Oros, Christian S Adams, et al.
Cureus (2023)
Open Access | Times Cited: 1
Prednisone/tozinameran

Reactions Weekly (2023) Vol. 1983, Iss. 1, pp. 395-395
Closed Access
Page 1

Scroll to top